Jackson Square Capital LLC Sells 5,271 Shares of Lam Research Corporation $LRCX

Jackson Square Capital LLC trimmed its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 17.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,954 shares of the semiconductor company’s stock after selling 5,271 shares during the period. Jackson Square Capital LLC’s holdings in Lam Research were worth $3,341,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Sava Infond d.o.o. boosted its stake in shares of Lam Research by 3.1% in the 2nd quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock valued at $7,325,000 after purchasing an additional 2,250 shares in the last quarter. Horizon Bancorp Inc. IN acquired a new position in Lam Research in the second quarter worth $389,000. Empowered Funds LLC grew its holdings in shares of Lam Research by 10.5% during the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after purchasing an additional 17,833 shares during the last quarter. Genus Capital Management Inc. acquired a new stake in shares of Lam Research in the second quarter valued at $14,476,000. Finally, Glass Wealth Management Co LLC raised its holdings in shares of Lam Research by 8.5% in the second quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock valued at $2,810,000 after buying an additional 2,270 shares during the last quarter. 84.61% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 102,608 shares of company stock valued at $14,916,496 in the last ninety days. 0.31% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. TD Cowen boosted their target price on shares of Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Zacks Research downgraded Lam Research from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. UBS Group reiterated a “buy” rating and issued a $175.00 price objective (up from $165.00) on shares of Lam Research in a research report on Tuesday, November 25th. JPMorgan Chase & Co. boosted their target price on Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 23rd. Finally, BNP Paribas Exane raised their price target on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $160.37.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple sell‑side upgrades and price‑target increases from major firms lift sentiment and implied upside — B. Riley raised its target to $195 and maintained a buy rating. Article Title
• Positive Sentiment: Deutsche Bank raised its target to $195 and reiterated a buy, citing stronger forward visibility; that adds another institutional vote of confidence. Article Title
• Positive Sentiment: Mizuho lifted its price target to $200 from $170, maintaining an outperform view — another sizable increase that signals analysts expect stronger 2026 demand. Article Title
• Positive Sentiment: Coverage roundup: three firms turned bullish on LRCX today, a concentrated shift that drove short‑term buying interest. Article Title
• Positive Sentiment: Technical momentum: LRCX just flashed a golden‑cross (longer MA crossing above shorter MA) and cleared the 20‑day moving average — a buy signal that attracts momentum traders. Article Title
• Positive Sentiment: Investor recognition: IBD named Lam an “IBD Stock of the Day” and noted all‑time high momentum tied to 2026 prospects, which can attract retail inflows. Article Title
• Neutral Sentiment: Analysis pieces and price‑range summaries reflect consensus views and model updates (price forecasts shown from ~$175 to $210) — useful context but not a direct catalyst on its own. Article Title
• Neutral Sentiment: Feature coverage (Forbes) reviews the drivers behind today’s move and the 2026 thesis; good background for investors but largely descriptive. Article Title
• Neutral Sentiment: Corporate/community items (annual collegiate challenge winners) are positive PR but unlikely to move the stock materially. Article Title

Lam Research Stock Up 4.6%

Shares of Lam Research stock opened at $172.27 on Friday. The firm has a market cap of $216.38 billion, a PE ratio of 37.95, a P/E/G ratio of 1.69 and a beta of 1.77. The business’s 50 day simple moving average is $154.83 and its 200 day simple moving average is $122.80. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $173.58.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period last year, the business earned $0.86 EPS. The business’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.